Palo Alto Veterans Institute For Research

Palo Alto Veterans Institute For Research, doing business as Pavir, is a tax-exempt nonprofit research organization based in Palo Alto, California that functions as a federal grant recipient focused on biomedical and behavioral research relevant to veteran and aging populations. Pavir operates predominantly as a prime recipient on federal project grants (72% of recent awards) rather than as a contractor or subcontractor, with a portfolio centered on neuroscience, cardiovascular, immunological, and translational research aligned with the missions of the National Institutes of Health, the Defense Health Agency, and the Department of the Army Medical Command.

Pavir's research footprint spans multiple NIH institutes and centers. The National Institute on Aging funds work on Alzheimer's disease treatment mechanisms, metabolic aging, and chromatin signaling in age-related pathology; recent awards include a $301,575 project grant on lecanemab combined with exercise for Alzheimer's disease and a $596,400 award investigating ketogenesis and the liver-gut axis in aging. The National Heart Lung and Blood Institute backs cardiovascular research, including a $630,000-plus award on epigenetic mechanisms in abdominal aortic aneurysm and a lymphedema-prevention device award. The National Institute on Alcohol Abuse and Alcoholism supports a $1.09 million randomized trial of deep transcranial magnetic stimulation for alcohol use disorder. The National Institute of Mental Health and the Defense Health Agency jointly fund PTSD research using neuromodulation approaches and behavioral interventions, including a $2.40 million DHA award on behavioral health technician-delivered written exposure therapy and additional projects on transcranial magnetic stimulation targeting the default mode network. Work on military-relevant cardiovascular pathology is funded by the Defense Health Agency and includes a $1.16 million award on endothelial-to-mesenchymal transition in veterans with burn pit exposure and a $923,000 grant on lung cancer engagement in veterans. Pavir also holds awards from the National Institute of Neurological Disorders and Stroke, the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the National Center for Complementary and Integrative Health, with research spanning neuroimmune pain mechanisms, lymphedema and lymphatic regeneration, transplant immunology, and telehealth-delivered yoga for chronic pain in veterans.

Customer concentration is substantial among NIH institutes. The Department of Health and Human Services National Institutes of Health accounts for 79 awards across its component institutes (National Institute on Aging at 27 awards, National Heart Lung and Blood Institute at 33, and others), with the Defense Health Agency placing 26 awards valued at $8.6 million in combined potential value. The top five funding organizations account for 60% of awards by count; however, the potential-value ranking is dominated by the Defense Health Agency's $8.6 million combined potential value, signaling that while NIH award volume is high, Defense and military health research carries the largest individual award magnitudes in Pavir's current footprint.

Pavir operates as a sub-recipient on multiple NIH-funded research grants, primarily partnering with Stanford University, The Leland Stanford Junior University, and the Henry M. Jackson Foundation for the Advancement of Military Medicine. Sub-awards document detailed collaborations: Pavir's facility at VA Palo Alto Health Care System (VAPAHCS) provides MRI infrastructure, tissue processing, mouse models, and clinical recruitment for Stanford-led consortium research on cardiovascular imaging, atrial fibrillation, ventricular tachycardia, and neurodegenerative disease. The vendor also partners as sub-recipient with Johns Hopkins University, Weill Cornell, the University of Texas Health Science Center at San Antonio, Drexel University, and others on specific aims requiring Pavir's technical capacity, veteran patient access, or specialized animal facilities.

Recent activity shows accelerating grant volume — six awards in 2022 to a peak of 40 in 2024, followed by 22 in 2025 and 18 in 2026 year-to-date — suggesting sustained or growing federal investment in Pavir's research infrastructure and mission-aligned science. Eighteen awards face ultimate completion within the next twenty-four months and thus carry recompete exposure. Service Contract Inventory data captures minimal activity, with only two SCI records (both sub-engagements) documenting 5.3 FTEs in FY2022 and 0.4 FTEs in FY2024, indicating that Pavir's federal footprint is grant-funded research delivery rather than service-contract labor.